FDA Calls on Retailers to Remove Illegal E-Cigarettes from Shelves, Will Send List of Legal Products to 300,000 Stores

Oct.08
FDA Calls on Retailers to Remove Illegal E-Cigarettes from Shelves, Will Send List of Legal Products to 300,000 Stores
FDA launches national retail compliance initiative to combat illegal e-cigarette sales targeting youth, issuing guidance materials to over 300k retailers.

Key points:

 

Action Background: The Director of the FDA, Marty Makary, has announced the launch of a nationwide retailer compliance initiative.

 

Market situation: According to the FDA's estimate, approximately 54% of e-cigarette products on the U.S. market are illegal, with some specifically designed for teenagers, containing flavors such as fruit and candy, and even featuring built-in Bluetooth speakers or gaming capabilities.

 

Health Risk Alert: Industrial chemicals detected in illegal e-cigarettes. These substances are commonly used in the manufacturing of textiles, plastics, and insecticides, and prolonged inhalation may pose serious risks to human health.

 

Key regulatory measures: The FDA will send guidance materials to over 300,000 retail establishments across the United States.

  1. The guidance includes a list of 39 approved e-cigarette products and 20 nicotine pouch products; 
  2. an introduction to the FDA's new "Tobacco Product Search Database" covering over 17,000 legal products; 
  3. retail education materials such as posted reminders that customers must be 21 years old or older to purchase tobacco products.

 

2Firsts, October 8, 2025 - According to the official website of the US Food and Drug Administration (FDA), in an effort to crack down on illegal e-cigarette products and protect the health of young people, FDA Director Marty Makary issued a statement on September 30, officially launching a new initiative aimed at retailers, calling on retail channels including e-cigarette stores, convenience stores, and gas stations to voluntarily cease the sale of illegal e-cigarette products.

 

This initiative aims to enhance retailers' awareness of the legal range of products for sale. The FDA stated that many retailers in communities are still selling illegal e-cigarettes specifically targeted at teenagers with fruit or candy flavors, and even products with built-in video games or Bluetooth speakers. These products are largely unauthorized by the FDA and primarily come from illegal imports from China.

 

According to the FDA's estimate, approximately 54% of e-cigarette products sold in the United States are illegal.

 

These illegal products often contain harmful substances such as formaldehyde, lead, and acetaldehyde, which are commonly used in industrial textiles or insecticides. Prolonged use of these ingredients can pose serious health risks to the human body.

 

In order to help retailers clarify the boundaries between legal and illegal products, the FDA will be sending guidance materials to over 300,000 retail outlets nationwide. The contents include:

 

  • Currently, there are 39 e-cigarette products and 20 nicotine pouch products approved for sale in the US market. This list includes a QR code link to the FDA website for real-time updates. 
  • The FDA has recently launched a Tobacco Product Database, which covers over 17,000 legally marketed tobacco products, including cigarettes, cigars, hookah, and e-cigarettes. 
  • The latest educational materials for retailers, such as calendar-style reminders, emphasize that tobacco products can only be sold to customers aged 21 and above, and photo identification must be checked for customers under the age of 30.

 

Commissioner Makari emphasized:

 

We know that most businesses have a willingness to comply with the law. The goal of this new initiative is to eliminate information blind spots and leave retailers no excuse to sell illegal products.

 

He expressed a particular hope to curb the circulation and sale of illegal e-cigarette products through this action, as these products are currently widely used among young people.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
Russian State Duma Committee supports bill for tobacco and nicotine products market legalization
Russian State Duma Committee supports bill for tobacco and nicotine products market legalization
A bill endorsing a licensing system for tobacco and nicotine products has been recommended in Russia's State Duma.
Nov.14 by 2FIRSTS.ai
Mexican Congress Postpones Debate on Vape and E-Cigarette Ban
Mexican Congress Postpones Debate on Vape and E-Cigarette Ban
Mexico’s Chamber of Deputies has postponed the debate on a reform to the General Health Law that seeks to completely ban the sale and distribution of electronic cigarettes and vapes. Lawmaker Amancay González Franco (MC) criticized the draft for excluding tobacco heating devices, such as Philip Morris’s IQOS, arguing that these products are even more harmful according to the World Health Organization.
Dec.05 by 2FIRSTS.ai
Mexico moves to advance reforms regulating e-cigarettes and vapes
Mexico moves to advance reforms regulating e-cigarettes and vapes
Mexico’s Chamber of Deputies Health Committee is expected to vote next week on reforms to the General Health Law that would regulate the prohibition, distribution, and sale of electronic cigarettes, vapes, and certain toxic substances, including fentanyl. Lawmakers from Morena insist the legislation must avoid loopholes and resist pressure from the tobacco industry.
Nov.21 by 2FIRSTS.ai
Nicoventures Granted Rehearing After Philip Morris Challenge Rejected
Nicoventures Granted Rehearing After Philip Morris Challenge Rejected
Nicoventures Trading Ltd., a subsidiary of British American Tobacco (BAT), has won an appeal at the European Patent Office (EPO), convincing the appellate board that examiners had violated its right to be heard by failing to review all of its submissions.
Dec.09 by 2FIRSTS.ai
India’s NUSRL Hosts National Consultation on Protection from Emerging Tobacco and Nicotine Products
India’s NUSRL Hosts National Consultation on Protection from Emerging Tobacco and Nicotine Products
The National University of Study and Research in Law (NUSRL) in Ranchi, together with national and international public health experts, held a consultation focused on youth protection, enforcement capacity, and the regulatory landscape for emerging nicotine products. State Health Minister Irfan Ansari called for stronger policies and coordinated efforts to prevent addiction.
Dec.02